Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price hits fresh 52-week high on 26 August 2026

Published: 26 August 2026 at 9:48 AM IST

Laurus Labs Share Price moved to Rs 1,868.40 on 26 August 2026, up Rs 3.40 or 0.18% from the previous close, while marking a fresh 52-week high of Rs 1,882. The company’s market capitalisation stands at Rs 97,053.58 crore. The move is relevant because the supplied data confirms the price event, but it does not establish any company-specific catalyst. For readers tracking Laurus Labs Share Price Today, the stock is now trading close to its yearly high and remains a major Stock News update in the Healthcare sector. Univest is tracking the event using only verified market data and benchmark comparisons.

The latest Laurus Labs Share Price action matters because it combines a fresh one-year high with a market capitalisation that places the company near the Rs 1 lakh crore mark. The session opened at Rs 1,878.85, traded between Rs 1,857.25 and Rs 1,882, and closed the visible move with a modest gain versus the prior close. Univest highlights this as a price event rather than a catalyst-led story, and the supplied figures support that distinction. In short, the Laurus Labs Share Price Today story is about a new yearly high, valuation context and sector comparison, not an unverified reason for the rise.

Laurus Labs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,868.4
Previous Close	Rs 1,865
Today's Move	+Rs 3.4 (+0.18%)
Open	Rs 1,878.85
High	Rs 1,882
Low	Rs 1,857.25
Turnover	Rs 2.22 crore
Market Capitalisation	Rs 97,053.58 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,868.4 versus the previous close of Rs 1,865, a rise of 0.18%. The stock opened at Rs 1,878.85, reached a high of Rs 1,882 and touched a low of Rs 1,857.25.

Laurus Labs Share Price Today finished at Rs 1,868.40 after opening at Rs 1,878.85, touching Rs 1,882 and slipping to an intraday low of Rs 1,857.25. The stock’s current price is Rs 3.40 above the previous close of Rs 1,865, which equals a 0.18% rise. The day’s high matched the fresh 52-week high, so the session confirmed a yearly high print rather than a broad intraday range beyond that mark. Turnover for the session was Rs 2.22 crore, which is the factual traded-value measure supplied for this move. For anyone following Laurus Labs Share Price Live, the key takeaway is that the stock is now priced near the top of its 52-week range after a measured gain. That makes Laurus Labs Share Price a headline Stock Market Today update and a notable entry in Stocks in News. Univest will continue to monitor the next session for price follow-through.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 97,053.58 crore
P/E Ratio	92.16x
P/B Ratio	17.87x
ROE	18.31%
ROCE	18.2%
EPS	Rs 20.24
Book Value Per Share	Rs 104.37
Dividend Yield	0.11%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 92.16x, P/B 17.87x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 97053.58 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 92.16x, P/B at 17.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.32x, median ROE of 11.81%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	92.16x
Benchmark Median P/E	30.32x
Benchmark Average P/E	46.52x
Benchmark P/E Range	2.94x to 717.81x
Company P/B Ratio	17.87x
Benchmark Median P/B	2.7x
Company ROE	18.31%
Benchmark Median ROE	11.81%
Company ROCE	18.2%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 97,053.58 crore
Benchmark Median Market Cap	Rs 599.92 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 92.16x, which is above the benchmark median of 30.32x, a difference of +203.96%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.81%, a difference of +55.04%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.75%, a difference of +32.36%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Mankind Pharma Ltd.	MANKIND	98,086.54	47.86	5.81	12.69	13.24
Dr. Reddy's Laboratories Ltd.	DRREDDY	99,702.02	30.85	2.6	11.69	13.75
Lupin Ltd.	LUPIN	1,00,134.44	17.99	4.18	27.11	28.86
Aurobindo Pharma Ltd.	AUROPHARMA	92,612.83	24.85	2.37	9.93	12.76
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,825.17	24.98	4.18	19.69	21.39

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 92.16x compared with the displayed peer median of 24.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 97,053.58 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs

• Laurus Labs Share Price hit a fresh 52-week high of Rs 1,882 and last traded at Rs 1,868.40.
• The day change was Rs 3.40, equal to a 0.18% rise from the previous close of Rs 1,865.
• Market capitalisation is Rs 97,053.58 crore, with P/E at 92.16 and P/B at 17.87.
• ROE is 18.31% and ROCE is 18.2%, both above the Healthcare sector medians supplied.
• Revenue for Jun 26 was Rs 20,263.1 crore and net profit was Rs 3,676 crore.

About Laurus Labs

Laurus Labs Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data positions the company within a benchmark set of 200 same-industry companies and 284 same-sector companies. Laurus Labs Share Price is therefore being followed not only as a stock event but also as a Healthcare sector data point on Univest. The company profile in this dataset is focused on financial and market metrics, so the article keeps to those verified fields without adding assumptions about business operations or growth drivers.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Users can track Laurus Labs Share Price on Univest for live price updates, 52-week levels, shareholding pattern, fundamental ratios, sector context and company insights. Univest also presents Laurus Labs Stock News, Laurus Labs Share Price Today and Laurus Labs Stock Analysis in a single research view, making it easier to review verified market data without speculation. If you follow Laurus Labs Share Price Live, the Univest page keeps the latest event, valuation and peer context in one place.

Frequently Asked Questions

Why is Laurus Labs Share Price in the news today?

Ans. Laurus Labs Share Price is in focus because it reached a fresh 52-week high of Rs 1,882 and last traded at Rs 1,868.40, with a 0.18% rise from the previous close.

What is the latest Laurus Labs Share Price Today?

Ans. Laurus Labs Share Price Today is Rs 1,868.40. The stock opened at Rs 1,878.85, hit a high of Rs 1,882 and recorded a low of Rs 1,857.25 during the session.

What does the fresh 52-week high mean for Laurus Labs?

Ans. The fresh 52-week high means Laurus Labs touched Rs 1,882 during the session. It confirms a yearly high print and places the current share price close to the top of its 52-week range.

How is Laurus Labs valued on the supplied data?

Ans. Laurus Labs has a P/E of 92.16 and a P/B of 17.87. Both are above the Healthcare sector medians in the supplied benchmark, so the valuation sits at a premium to that reference set.

What do Laurus Labs profitability metrics show?

Ans. Laurus Labs reports ROE of 18.31% and ROCE of 18.2%, both above the sector medians supplied. EPS is Rs 20.24 and book value is Rs 104.37 per share. ROE stands at 18.31%.

How does Laurus Labs compare with Healthcare peers?

Ans. Laurus Labs Share Price is supported by a market cap of Rs 97,053.58 crore. Its P/E and P/B are higher than the listed peers, while ROE and ROCE sit above some peers and below others.